Skip to main content
. Author manuscript; available in PMC: 2023 Sep 28.
Published in final edited form as: JACC Heart Fail. 2022 Mar 9;10(4):266–275. doi: 10.1016/j.jchf.2021.12.004

Central Illustration: Impact of frailty on clinical outcomes and optimization of GDMT.

Central Illustration:

HFrEF patients with a higher burden of frailty are less likely to be initiated on GDMT and have dose escalation, despite being at a higher risk for adverse clinical outcomes.